Suppression of F ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?

Shoaib Faruqi; Sean Zhou; Joanne Thompson; Terry Robinson; Karen Watkins; Helena Cummings; Nicola Jackson; Anoop Prakash; Michael Crooks

doi:10.1183/23120541.00123-2019

Suppression of F _ENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?

ERJ Open Res. 2019 Nov 25;5(4):00123-2019. doi: 10.1183/23120541.00123-2019. eCollection 2019 Oct.

Authors

Shoaib Faruqi¹, Sean Zhou¹, Joanne Thompson¹, Terry Robinson², Karen Watkins¹, Helena Cummings¹, Nicola Jackson¹, Anoop Prakash¹, Michael Crooks¹

Affiliations

¹ Castle Hill Hospital, Respiratory Medicine, Cottingham, UK.
² Harrogate and District NHS Foundation Trust, Respiratory, Harrogate, UK.

Abstract

F _ENO suppression testing is practical and feasible during assessment for biologics in severe asthma. Patients with significant F _ENO suppression were less likely to be recommended biologics but saw similar reductions in exacerbation frequency. http://bit.ly/35oSoxP.